Joep Killestein
scientific advisor
pharmaceutical science
Echo pharmaceutical
Netherlands
Biography
Joep Killestein is a Staff Neurologist at Free University Medical Centre and MS Centre Amsterdam since 2006. He completed his PhD training on T-cell functions in treated and untreated MS patients in 2002. The main focus of his current research is on the correlation between (immune) biomarkers and response to disease modifying therapies in MS, i.e. the response to interferon-beta (IFNβ), fingolimod and natalizumab. He has been involved in several clinical trials in Multiple Sclerosis, including those testing safety and efficacy of IFNβ, T and B cell depletion, natalizumab, cladribine, fingolimod and cannabinoids.
Research Interest
Pharmacogenomics & Pharmacoproteomics
